Key Takeaways
- Stable quarter, antidumping catalyst ahead: Revenue was flattish sequentially at ₹336 crores, but the government has initiated antidumping investigations on key products, with an outcome expected in the coming months.
- Export engine running despite global stagnation: Export volumes grew moderately even as global rubber chemical demand grew barely 2%, with NOCIL clocking double-digit export growth over the last two years.
- Raw material tailwind emerging: Aniline prices corrected 25–30% in the last 3–4 months; most inventory loss hit Q1, positioning the company for lower input costs ahead.
- Dahej expansion on track, with demand visibility: Trial production is expected in H1 FY27, with revenues in H2 FY27; the product already runs at high utilization and serves both tire and non-tire sectors.
- What to watch next quarter: The antidumping investigation outcome, the pace of volume growth recovery, and whether the aniline price correction flows through to margins.
Antidumping Proceedings
- Petitions filed, investigations underway: NOCIL filed antidumping petitions on some of its key products; the government found merits and initiated detailed investigations, with an outcome expected in the coming months.
- Product scope is targeted: The petition covers 3 old products and 1 new one: main antioxidants (Pilflex 13 and TDQ) and a set of Sulphenamides, not all 6 products.
- Financial impact unquantified: Management declined to estimate any incremental EBITDA from a potential duty, calling it too premature while the investigation is ongoing.
Srinivasan: "I think it's too premature to comment on it because it is under investigation process, and the government will study and make their own calculations and then come out. So I think it's too premature to even quantify any impact effect on that."
Demand Environment & Volume Growth
- Domestic market under dumping pressure: While export volumes showed moderate growth, the domestic market continued to experience dumping pressure, prompting a judicious mix of price and volume play.
- Global rubber chemical demand is sluggish: China grew ~1.9% last year, India 3.1%, Europe de-grew 7% in 2023 before marginal 5% growth in 2024, and the USA de-grew 5% in 2024. Overall global growth is hardly 2%.
- Export growth moderated by latex headwinds: Export volume growth was 3.5%, held back because the latex product suffered degrowth on account of temporary U.S. tariff uncertainty in Southeast Asia.
- Volume growth aspiration is double-digit: Management aspires to double-digit volume growth, but last financial year delivered about 4%; volume was still positive sequentially in Q1.
- Market share flat: Volume-wise, market share has been pretty much flat over the last 2 to 3 years.
Anand: "The aspiration and the plans are clearly to look at double-digit volume growth, but it will be difficult to put my finger on to say how much — where will it be precisely in this calendar year."
Export & Customer Expansion
- Export momentum sustained by approvals: Export business continues to demonstrate growth momentum, supported by incremental approvals from different locations from long-standing international customers.
- Japanese tire companies onboarded: NOCIL has started supplying to Japanese tire companies, which are at different stages of supply chain derisking with multiple products and multiple sites.
- Customer engagement is strategic and gradual: Expansion with each customer begins first with Asia, then Europe, then parts of North and South America.
- Product approvals span a wide basket: Products and projects are at different stages of approval, from sampling to commercial volumes, across a wider basket of products, not just 1 or 2.
Costs, Margins & Operational Efficiency
- Conversion cost rose on higher activity: Production of intermediates and finished goods increased about 15–20% sequentially, pushing conversion cost higher, though the increase was not proportionate to the activity rise.
- Inventory loss from falling raw material prices: Aniline prices corrected roughly 25–30% in the last 3–4 months; most of the inventory loss effect hit Q1, with a small portion possibly pending in Q2 in the form of finished goods.
- Power cost savings from new turbine: A turbine has been commissioned and, despite stabilization challenges, is expected to be a significant saver for utility cost, though management declined to quantify the savings, calling the data sensitive.
- Margin improvement path is multi-pronged: Management will try to improve competitiveness through a combination of product mix, cost saving measures, and volume consolidation at certain key accounts.
- Operating leverage potential: Every 10% increase in the capacity utilization index (from 130–135 to 145) will optimize some overheads.
Srinivasan: "I think, Nirav, you should appreciate, these are all sensitive data we have to be guarded against. Yes, in a way, it's significant from a utility budget perspective. That's all — that's the only point we can say at this point of time."
Capacity Expansion & New Products
- Dahej expansion has strong demand visibility: The product is used across the rubber sector, both tire and non-tire; NOCIL is already quite full on utilization and has debottlenecked over past years, making volume expansion critical.
- Capex timeline is defined: Trial production is expected to start during H1 FY27; post trials and customer approvals, revenues should kick in sometime in H2 FY27.
- Existing capacity provides runway: Current utilization at 65% provides room to grow to 80–90% before the new facility comes online.
- New products in the pipeline: 2–3 products are in development, one at customer trials; some commercialization is expected towards the end of the year, though volume ramp-up will take time.
- No extra capital needed initially: New products can be manufactured at the current facility without additional capital expenditure.
Strategic Positioning & Long-Term Ambition
- Long-term market share target is 10%: Management aims for a 10% share in the global rubber chemical space, which requires a performance CAGR of 10% in the medium to long term.
- Favorable positioning not yet fully reflected: Economies of scale in the ability to supply key products in sizable volumes contribute to a favorable positioning that is not completely reflected in the numbers yet.
- Eight strategic levers articulated: Management has elaborated on 8 strategic levers in the annual report, with focus on intensifying presence with key customers, sweating assets, driving operational excellence, and accelerating new product commercialization.
- Uncertain environment demands contingency planning: Management emphasized continuing to focus on basics and having a plan B and a plan C for every plan, given the uncertain operating environment.
Anand: "Given the environment that we are operating in, which is quite uncertain, I think we'll have to continue to focus on our basics. We will have to continue to focus on what we can do, which is within our control that is best-in-class so that we can be competitive globally and have a plan B and a plan C for every plan that we make."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Antidumping investigation outcome | Outcome of detailed government investigation on 4 products | "Coming months" |
| Dahej expansion trial production | Trial production to start at new facility | H1 FY27 |
| Dahej expansion revenue contribution | Revenues to kick in post trials and customer approvals | H2 FY27 |
| New product commercialization | 2–3 products in pipeline, one at customer trials; commercialization expected | Towards end of the year |
| Indian tire industry growth | Mid-single-digit growth on healthy replacement demand | Ongoing year |
| Long-term market share target | 10% share in global rubber chemical space, requiring 10% CAGR | Medium to long term |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Revenue from operations | ₹336 cr, flat sequentially vs ₹340 cr in Q4 FY25 |
| Sales volume index | 133 (Q1 FY20 = 100), stable QoQ |
| Export volume growth | 3% to 3.5%, moderated by latex degrowth from U.S. tariff uncertainty |
| Capacity utilization | 65% to 67%, average across all products |
| Domestic market share | ~40% |
| Products under antidumping investigation | ~40% of total business, covering Pilflex 13, TDQ, and a set of Sulphenamides |
| U.S. share of total business | 4% to 5% |
| Capex spent (₹250 cr budget) | ~30% expended as of March 2025, in CWIP |
| Asset turnover ratio (target) | 1.8 to 2.2x for rubber chemicals business |
| New capacity revenue start | H2 FY27 expected, post trials and customer approvals |
| Global rubber chemicals market growth | ~2% overall; China +1.9%, India +3.1%, Europe +5% in 2024 after -7% in 2023, U.S. -5% in 2024 |
| FY25 volume growth | ~4% |
| FY25 power cost | ~₹146 cr |
| FY25 margin | 10%, down from 14% in FY24 |
| Long-term global market share target | 10% |